palladium has been researched along with Retinal Detachment in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finger, PT; Maheshwari, A | 1 |
| Finger, PT; Semenova, E; Simhaee, D | 1 |
| Aizman, A; Berson, A; Finger, PT; Shabto, U; Szechter, A | 1 |
1 trial(s) available for palladium and Retinal Detachment
| Article | Year |
|---|---|
Palladium 103 (103Pd) plaque radiation therapy for circumscribed choroidal hemangioma with retinal detachment.
Topics: Aged; Brachytherapy; Choroid Neoplasms; Female; Fluorescein Angiography; Follow-Up Studies; Hemangioma; Humans; Male; Middle Aged; Palladium; Prospective Studies; Radioisotopes; Radiotherapy Dosage; Retinal Detachment; Ultrasonography; Visual Acuity | 2004 |
2 other study(ies) available for palladium and Retinal Detachment
| Article | Year |
|---|---|
Regression patterns of choroidal melanoma: After palladium-103 (
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Choroid Neoplasms; Female; Fluorescein Angiography; Humans; Male; Melanoma; Middle Aged; Palladium; Radioisotopes; Regression Analysis; Retinal Detachment; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Uveal Neoplasms; Visual Acuity; Young Adult | 2018 |
Regression of macular drusenoid retinal pigment epithelial detachments after plaque radiation therapy.
Topics: Aged; Brachytherapy; Choroid Neoplasms; Humans; Male; Melanoma; Palladium; Radioisotopes; Radiotherapy Dosage; Retinal Detachment; Retinal Drusen; Retinal Pigment Epithelium; Tomography, Optical Coherence | 2015 |